Follow up after treatment of CIN;Opvolging na afwijkende cervixcytologie

Tijdschrift voor Geneeskunde

Volumn 61, Issue 2, 2005, Pages 129-134

  Weyers, S ^a,b   Crijns, P ^a,c   De Sutter, P ^a,d   Ide, P ^a,e   Orye, G ^a,f   Poppe, W ^a,g   Tjalma, W ^a,h   Verguts, J ^a,g   Watty, K ^a,i   Wuyts, K ^a,j  

^a Vlaamse Werkgroep Oncol Gynaecol   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c KLINA   (Belgium)

^d AZ VUB   (Belgium)

^e Salvator Hospital   (Belgium)

^f VIRGA JESSE HOSPITAL   (Belgium)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ Stedelijk Ziekenhuis Roeselare   (Belgium)

^j Heilig Hart Ziekenhuis   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER SCREENING; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 19944433897     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/tvg.61.2.5002080     Document Type: Review

References (19)

1. SOLOMON D, DAVEY D, KURMAN R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-2119.
2. ROBB JA. The "ASCUS" swamp. Diagn Cytopathol 1994; 11: 319-320.
3. STOLER MH, SCHIFFMAN MH. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS LSIL Triage Study. JAMA 2001; 285: 1500-1505.
4. WRIGHT TC, COX JT, MASSAD LS, TWIGGS LB, WILKINSON EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 257: 2120-2129.
5. JONES BA, NOVIS DA. Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med 2000; 124: 665-671.
6. RONNETT BM, MANOS MM, RANSLEY JE, et al. Atypical glandular cells of undeterminded significance (AGUS): cytopathologic features, histopathologic results and human papillomavirus DNA detection. Hum Pathol 1999; 30: 816-825.
7. ZWEIZIG S, NOLLER K, REALE F, COLLIS S, RESSEGUIE L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997; 65: 314-318.
8. NASIELL K, ROGER V, NASIELL M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986; 67: 665-669.
9. DE CABEZON RH, SALA CV, GOMIS SS, LLISO AR, BELLVERT CG. Evaluation of cervical dysplasia treatment by large loop excision of the transformation zone (LLETZ). Does completeness of excision determine outcome? Eur J Obstet Gynecol Reprod Biol 1998; 78: 83-89.
10. GONZALEZ DI Jr, ZAHN CM, RETZLOFF MG, MOORE WF, KOST ER, SHYDER RR. Recurrence of dysplasia after loop electrosurgical excision procedures with long-term follow-up. Am J Obstet Gynecol 2001; 184: 315-321.
11. NASIELL K, NASIELL M, VACLAVINKOVA V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983; 61: 609-614.
12. WRIGHT TC Jr, COX JT, MASSAD LS, TWIGGS LB, WILKINSON EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003; 189: 295-304.
13. RICHART RM, BARRON BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969; 105: 386.
14. JAKUS S, EDMONDS P, DUNTON C, KING SA. Margin status and excision of cervical intraepithelial neoplasia: a review. Obstet Gynecol Surv 2000; 55: 520-527.
15. Cox JT, LÖRINCZ AT, SCHIFFMAN MH, SHERMAN ME, CULLEN A, KURMAN RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytological diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 772: 946-954.
16. FRANCO EL. Statistical issues in studies of HPV-infection and cervical cancer. In: Franco E, Monsonego J, eds. New developments in cervical cancer screening and prevention. Oxford: Blackwell, 1997: 39-50.
17. BOLLEN LJ, TJONG-A-HUNG SP, VAN DER VELDEN J, et al. HPV-DNA detection in mildly or moderately dysplastic cervical smears: a possible method for selecting patients for colposcopy. Am J Obstet Gynecol 1997; 777: 548-553.
18. JAIN S, TSENG JH, HORNG SG, SONG YK, PAO CC. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 2001; 82: 177-180
19. NAGAI Y, MACHAMA T, ASATO T, KANAZAWA K. Persistance of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 2000; 79: 294-299.